Fairfield, New Jersey – For Parker Laboratories, Inc., the world leader in the development, manufacturing and marketing of medical ultrasound and electromedical products, 2018 marks 60 years of commitment to the advancement of healthcare and the medical ultrasound industry.
Since its development and introduction of the first medical ultrasound gel, Aquasonic® 100 in 1958, Parker has expanded its product portfolio and its facilities to reflect healthcare’s ever-growing reliance on medical ultrasound. “It has been a remarkable journey. As we continue on this trajectory, we anticipate launching at least three new products during our 60th year as well as more than doubling the size of our headquarters, and by expanding our manufacturing facilities by almost 50 percent.” states Neal Buchalter, president of Parker Laboratories.
Since 1958, Parker Laboratories has been consistently positioned at the forefront of technological advances that characterize the ultrasound and electromedical industries. Parker’s flagship product, Aquasonic® 100 Ultrasound Transmission Gel, is the world standard for medical ultrasound.